Health Economic Modelling
Health economic modelling to support decision-making
We help pharmaceutical companies bring their products to the right patients at the right time and right price.
We assist pharmaceutical companies in bringing a new drug to the right patient group promptly and at an optimal price. Our support is always available for Market Access experts, managers, directors, and business units, whether it involves evaluating healthcare interventions, health economic modeling, pricing and reimbursement applications, risk-sharing agreements and models, or market analytics.
Medaffcon is a full-service provider in Market Access. In our services, we offer strategic and tactical advice and expert services, especially for pharmaceutical companies, covering all phases of market entry and subsequent phases of the product lifecycle.
The goal of Market Access activities is to ensure that new technology, such as a drug, reaches the right patient group as quickly as possible after obtaining marketing authorization at a price that is optimal for healthcare providers, payers, and the marketing authorization holder. This activity aims to mitigate or remove non-medical barriers to the use of technology.
Medaffcon excels in the evaluation of healthcare methods, health economic modeling, pricing and reimbursement applications, interactive tools and calculators, risk-sharing models, and market analysis based on real-life data.
We have carried out dozens of market access projects annually for 15 years, which gives us a broad and insightful expertise. Our active collaboration with authorities, like Fimea, the Pharmaceuticals Pricing Board, and the scientific community ensures that our information is up-to-date and that we can consider the challenges and perspectives of all stakeholders.
Our experts work closely with clients’ Market Access directors, managers, and specialists, as well as business accountables. We provide knowledgeable support, whether it involves the drug pricing and reimbursement application process, strategic market entry planning, or current trends in the pharmaceutical industry.
We are familiar with the local operational environment and national peculiarities, which leads to a smooth Market Access process.
We take on an expert role and operate solution-focused throughout all stages of market access projects.
We are reliable and honest. We do not overpromise and address critical issues in a timely manner. We advocate for our clients and avoid unnecessary work.
Health economic modelling to support decision-making
Medicinal products' pricing and reimbursement processes
Large data entities presented in practical, interactive tools
Easy-to-use reporting tool designed to support decision making in pharmaceutical sales and marketing
Risk-sharing agreements' planning and contract negotiations
Sweden and Finland are leaders in developing and applying health technology and provide ideal environments for conducting Health Technology Assessments (HTA) for medical devices.
Are you employed in the pharmaceutical industry and seeking insights into your product's position within the Finnish market? Then Patient Dynamics is the ideal tool for you. Developed by Medaffcon, Patient Dynamics caters to the needs of pharmaceutical companies by providing precise information for sales and marketing decision-making.
“Renewable drug therapy challenges the current complex drug evaluation system,” states Lauri Pelkonen, a leading expert at the Ministry of Social Affairs and Health (STM). For this reason, the evaluation activity is being reformed to better respond to changes in the operating environment.
Market Access Lead
MSc (Health Sciences), BBA
+358 40 580 0567
simo.jaaskelainen@medaffcon.fi
Simo started as the leader of Medaffcon’s Market Access team in November 2024. He is a returnee, as he has also previously worked at Medaffcon. Before returning to Medaffcon, Simo worked in a pharmaceutical company as the head of a Market Access team and has also gained Market Access experience in other pharmaceutical companies. He has over 20 years of experience in the pharmaceutical industry. Simo holds a Master’s degree in Health Sciences and a Bachelor’s degree in Business Administration.
Simo brings to Medaffcon a strong and versatile background in the pharmaceutical industry, particularly in Market Access roles. His strengths include versatility, organizational skills, and the ability to see the bigger picture. In the field of Market Access, Simo does not consider himself an expert in any particular subfield but sees himself as a generalist. He is drawn to the challenges of the industry and the opportunity to find comprehensive solutions that meet the needs of clients.
Ongoing changes in the operating environment require pharmaceutical companies to adapt and adopt new ways of working. Simo believes that the role and importance of Market Access will become even more prominent in a situation where society’s willingness to pay and the needs of the pharmaceutical industry must be aligned in a way that benefits both parties.